Fineline Cube

Follow:
14499 Articles
BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes
CompanyDrug

BMS Secures NMPA Approval for Reblozyl in Myelodysplastic Syndromes

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products
CompanyDeals

Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License
CompanyDeals

Genrix Bio Partners with Cullinan Therapeutics for GR1803 License

AstraZeneca's Imfinzi Approved for Limited Stage Small Cell Lung Cancer in China
CompanyDrug

AstraZeneca’s Imfinzi Approved for Limited Stage Small Cell Lung Cancer in China

Akeso Biopharma Wins NMPA Approval for New Cadonilimab Indication
CompanyDrug

Akeso Biopharma Wins NMPA Approval for New Cadonilimab Indication

Salubris Pharmaceuticals' Allisartan-Indapamide Hybrid Wins NMPA Approval
CompanyDrug

Salubris Pharmaceuticals’ Allisartan-Indapamide Hybrid Wins NMPA Approval

Wantai Biopharm's Cecolin 9 HPV Vaccine Approved by China's NMPA
CompanyDrug

Wantai Biopharm’s Cecolin 9 HPV Vaccine Approved by China’s NMPA

Biocytogen and Chia Tai Tianqing Win NMPA Approval for NTB003 Clinical Trials
CompanyDrug

Biocytogen and Chia Tai Tianqing Win NMPA Approval for NTB003 Clinical Trials

NMPA Accepts NDA for Innovent and HutchMed's Tyvyt and Elunate Combination
CompanyDrug

NMPA Accepts NDA for Innovent and HutchMed’s Tyvyt and Elunate Combination

SciBrunch Therapeutics Secures RMB 200 Million in Angel Financing Round
CompanyDeals

SciBrunch Therapeutics Secures RMB 200 Million in Angel Financing Round

JW Therapeutics' Carteyva Approved by Macau Health Bureau
CompanyDrug

JW Therapeutics’ Carteyva Approved by Macau Health Bureau

Sichuan Kelun-Biotech Raises $250M in Hong Kong's Largest Follow-On Offering
CompanyDeals

Sichuan Kelun-Biotech Raises $250M in Hong Kong’s Largest Follow-On Offering